• Skip to primary navigation
  • Skip to main content
BC

biochimica clinica

en_US English
en_US English it_IT Italian
  • Home
  • Case reports
  • Ahead of print e Ultimo Fascicolo - Accedi per visualizzare gli articoli
  • BC Issues until 2024
  • Submission
  • Istruction for authors
  • Search

DOCUMENTI - Documents

Volume:

Biochimica Clinica 2011; 35(6) 465-473

Published on-line:

DOI:

Download in PDF:
Authentication required

Guida all’uso clinico dei biomarcatori in oncologia: i marcatori nelle diverse neoplasie – Parte II

AUTHORS

Massimo Gion1, Chiara Trevisiol1,2, Silvia Pregno3, Aline S.C. Fabricio1,2 a nome dei Gruppi e Comitati di Progetto della Guida*
1Centro Regionale Biomarcatori, U.O. Laboratorio Analisi, Dipartimento di Patologia Clinica, Azienda ULSS 12 Veneziana,
2Fondazione ABO, Venezia
3GRADE Working Group, Cochrane Methodology Review Group, Castelvetro di Modena, MO

ABSTRACT

Guidelines for clinical use of biomarkers of different neoplastic diseases - Part II.

Guidelines for clinical use of biomarkers of different neoplastic diseases – Part II. This contribution represents the second of two parts of guidelines for clinical use of tumour biomarkers, reporting in schematic tables the evidencebased information available for different neoplastic pathologies (the first part was published on Biochim Clin 2011;35:394-403). Particularly, the following neoplastic conditions are considered in this document: testicular seminoma and non-seminoma, cervical uterine cancer, ovarian and renal cell carcinomas, breast cancer, melanoma, and neuroendocrine tumors.

REFERENCES